Page last updated: 2024-10-28

p-hydroxyamphetamine and Urinary Bladder, Overactive

p-hydroxyamphetamine has been researched along with Urinary Bladder, Overactive in 3 studies

p-Hydroxyamphetamine: Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.

Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.

Research Excerpts

ExcerptRelevanceReference
" The bioavailability of KUC-7322 was estimated to be 4%."1.40Absorption, disposition, metabolism, and excretion of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, in rats. ( Abe, Y; Endo, T; Kobayashi, M; Murakami, M; Ota, E, 2014)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, Y1
Ota, E1
Endo, T1
Murakami, M1
Kobayashi, M1
Maruyama, I2
Tatemichi, S2
Goi, Y2
Maruyama, K2
Hoyano, Y2
Yamazaki, Y2
Kusama, H2

Other Studies

3 other studies available for p-hydroxyamphetamine and Urinary Bladder, Overactive

ArticleYear
Absorption, disposition, metabolism, and excretion of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, in rats.
    Die Pharmazie, 2014, Volume: 69, Issue:12

    Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Animals; Area Under Curve; Bile; Biotransformation; F

2014
Effects of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, on bladder function in cynomolgus monkey.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:1

    Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Animals; Bloo

2012
Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat.
    Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:8

    Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic be

2012